Indication
Erosive esophagitis
Erosive esophagitis is an inflammatory gastrointestinal disorder characterized by endoscopically visible mucosal breaks, erosions, or ulcerations in the lining of the esophagus. Read more about Erosive esophagitis
524 drugs 216 manufacturers
Drugs that treat it
Common Erosive esophagitis therapies.
FAMOTIDINE (famotidine/PF)
ACID REDUCER (ranitidine HCl)
HEARTBURN TREATMENT (esomeprazole magnesium)
RANITIDINE HCL
RANITIDINE HCL
RANITIDINE HCL
LANSOPRAZOLE
LANSOPRAZOLE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonErosive esophagitis is an inflammatory gastrointestinal disorder characterized by endoscopically visible mucosal breaks, erosions, or ulcerations in the lining of the esophagus.
It predominantly represents an advanced phenotype of gastroesophageal reflux disease, arising when retrograde flow of gastric acid, pepsin, and bile overwhelms local epithelial defenses and induces tissue injury.
Patients typically present with symptoms such as heartburn, dysphagia, odynophagia, and regurgitation, though some individuals remain asymptomatic.
Pathophysiologically graded by severity—commonly using the Los Angeles classification—the condition carries a risk of progressive complications if unmanaged, including peptic stricture formation, upper gastrointestinal bleeding, and the development of Barrett esophagus.
- nih.gov
Erosive esophagitis is an inflammatory gastrointestinal disorder characterized by endoscopically visible mucosal breaks, erosions, or ulcerations in the lining of the esophagus It predominantly represents an advanced phenotype of gastroesophageal reflux disease, arising when retrograde flow of gastric acid, pepsin, and bile overwhelms local epithelial defenses and induces tissue injury Patients typically present with symptoms such as heartburn, dysphagia, odynophagia, and regurgitation, though s...
- nih.gov
Erosive esophagitis is an inflammatory gastrointestinal disorder characterized by endoscopically visible mucosal breaks, erosions, or ulcerations in the lining of the esophagus
- nih.gov
It predominantly represents an advanced phenotype of gastroesophageal reflux disease, arising when retrograde flow of gastric acid, pepsin, and bile overwhelms local epithelial defenses and induces tissue injury
- nih.gov
It predominantly represents an advanced phenotype of gastroesophageal reflux disease, arising when retrograde flow of gastric acid, pepsin, and bile overwhelms local epithelial defenses and induces tissue injury
- nih.gov
Patients typically present with symptoms such as heartburn, dysphagia, odynophagia, and regurgitation, though some individuals remain asymptomatic
- nih.gov
Pathophysiologically graded by severity—commonly using the Los Angeles classification—the condition carries a risk of progressive complications if unmanaged, including peptic stricture formation, upper gastrointestinal bleeding, and the development of Barrett esophagus
- nih.gov
Pathophysiologically graded by severity—commonly using the Los Angeles classification—the condition carries a risk of progressive complications if unmanaged, including peptic stricture formation, upper gastrointestinal bleeding, and the development of Barrett esophagus
- nih.gov
Pathophysiologically graded by severity—commonly using the Los Angeles classification—the condition carries a risk of progressive complications if unmanaged, including peptic stricture formation, upper gastrointestinal bleeding, and the development of Barrett esophagus
- nih.gov
Pathophysiologically graded by severity—commonly using the Los Angeles classification—the condition carries a risk of progressive complications if unmanaged, including peptic stricture formation, upper gastrointestinal bleeding, and the development of Barrett esophagus
Personalize your experience
Follow Erosive esophagitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.